The U.S. health care system has failed to address obesity in any meaningful way. Health plans could help. New evidence suggests that even minimal weight loss can result in short-term benefits.
Proponents can comfort themselves with the knowledge that DM is no longer seen as a marketing tool for drug companies.
A Conversation With William F. Jessee, M.D.
In a wide-ranging discussion, the MGMA’s chief decries the lack of consistency in medical-management rules across health plans.
A consultant and one-time HMO director of pharmacy services explains how to select and monitor a pharmacy benefit manager.
Percutaneous vertebroplasty is a minimally invasive procedure for patients with intractable pain. It could prove cost-effective.
DEPARTMENTS
Editor’s Memo
News and Commentary
JAMA Study Challenges Key HEDIS Diabetes Measure
Aetna Chief Quits Amid Share Price, Quality Concerns
Three-tier drug copayments in; closed formularies on way out? [charts]
Employers Predict Liability Expansion Bad for Coverage
Americans favor reform — but not too much [charts]
NCQA Unveils New PPO Accreditation Program, HEDIS ’01
Headlines on Deadline…
Washington Watch
State Initiatives
Compensation Monitor
Legal Forum
Managed Care Outlook
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.